-51%

est. 2Y upside i

Healthcare

Healthcare navigation and care coordination platform for employers

Rank

#3634

Sector

Healthcare Technology

Est. Liquidity

~3Y

Data Quality

Data: Low

The equity is likely unattractive with an expected downside of -50.9%.

Last updated: July 3, 2026

Bull (10%)+22%

Exit multiple expands to 3x as IPO window opens and category leadership recognized. Projected revenue $497M yields exit $1.49B, net of 10% dilution upside ~22%.

Base (50%)-34%

Exit multiple converges to public comp range ~1.5x, exit value $745.5M, well below $1.2B entry. After dilution, common shares lose ~34%.

Bear (40%)-90%

Multiple compresses to 0.8x, exit $397.6M below total funding $460M. Preference stack wipes out common, leading to ~-90% return after dilution.

Est. time to liquidity~3.0 years
Adjusted for competitive dynamics: -45% (raw: -51%, adjustment: +6%)

Preference Stack Risk

severe

Funding Intensity

112%

Total funding $460M versus estimated valuation $1.2B, 38% overhang, significant liquidation preference.

Dilution Risk

low

Company is profitable, unlikely to raise, dilution from option pool minimal.

Secondary Liquidity

none

No secondary market data available; liquidity only through IPO.

Other 2 roles

View all 2 open roles at Quantum Health

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Quantum Health's data — designed to show you've done your homework.

  • 1

    How does the platform differentiate from Optum and Evernorth?

  • 2

    What are the unit economics of the PMPM model and how can growth accelerate?

  • 3

    Given the data breach, what measures ensure data security and regulatory compliance?

Community

Valuation Sentiment

Our model estimates -51% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.